Article
A nomogram for predicting T315I-free survival in chronic phase chronic myeloid leukemia patients: a multicenter retrospective study.
Scientific reports - 18 Feb 2025
Hu Shi-Wei, Yang Xiu-di, Wu Di-Jiong, Wang Yi, Zhu Xiao-Qiong, Feng Wei-Ying, Qian Hong-Lan, Lu Ying, Chen Li-Li, Cao Li-Hong, Le Jing, Zhang Li, Shao Yan-Ping, Liu Li-Rong, Tian Guo-Yan, Zhou Hui, Chen Yu, Yin Xiu-Feng, Feng Xiao-Ning, Huang Li, Zhang Kai-Feng, Xia Yong-Ming, Xu Lin-Juan, Zhang Hui-Qi, Zhang Gang, Jia Yong-Qing, Zhou Xiu-Jie, Wu Gong-Qiang, Tu Jin-Ming, Zhu Feng, Zhang Yue-Feng, Yao Guo-Li, Zhu Jing-Jing, Tong Hong-Yan, Jin Jie, Huang Jian
Abstract excerpt
The T315I mutation poses a significant threat to patients with chronic phase chronic myeloid leukemia (CP-CML). This study aimed to establish a nomogram to predict the risk of T315I mutation in CP-CML patients. The training cohort included 1,466 patients from 24 hematology centers, and the validation cohort included 820 patients from an additional 20 centers. Peripheral blood blast (PBB), additional chromosomal...
Read the complete abstract on PubMedTopics
- Adolescent
- Adult
- Aged
- Female
